TLGT Insider Trading Activity and SEC Form 4 Filings
TLGT insider trading summary
No open-market insider purchases or sales of Teligent, Inc. (TLGT) have been reported on SEC Form 4 in the past 12 months.
Latest TLGT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 27, 2021 | R Carter Pate | Director | Buy | $16K (30,000 @ $0.55) |
| Aug 26, 2020 | Ben T Morris | 10% Owner | Sell | $591K (475,512 @ $1.24) |
| Aug 26, 2020 | Life Sciences Opportunities Fund Instittutional II LP | Director | Sell | $591K (475,512 @ $1.24) |
| Aug 26, 2020 | Donald V Weir | 10% Owner | Sell | $591K (475,512 @ $1.24) |
| Aug 26, 2020 | Don A Sanders | 10% Owner | Sell | $591K (475,512 @ $1.24) |
| Aug 26, 2020 | James C Gale | Director | Sell | $591K (475,512 @ $1.24) |
| Aug 26, 2020 | Don A Sanders | 10% Owner | Sell | $106K (85,106 @ $1.25) |
| Aug 26, 2020 | Signet Healthcare Partners, LLC | 10% Owner | Sell | $591K (475,512 @ $1.24) |
| Aug 26, 2020 | Life Sciences Opportunities Fund II LP | 10% Owner | Sell | $591K (475,512 @ $1.24) |
| Aug 26, 2020 | Life Sciences Opportunities Fund Instittutional II LP | Director | Sell | $106K (85,106 @ $1.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.